Insider filing · VRNA

Christina Ackermann sold $338K of Verona Pharma (VRNA)

Executed May 14 2025, disclosed May 16 2025, 2 days later.

Returns are measured on stock purchases only.

CA Christina Ackermann Director profile →

Christina Ackermann (Director) filed 2 Form 4 reports in the past 24 months (1 purchase, 1 sale), most often in VRNA. The largest single filing was $338K of VRNA (40,000 sh × $8.44, as filed), executed May 14 2025. The median gap between execution and disclosure was 1 day.

VRNA VRNA VRNA · 40 filings in 24 months ticker → Insider filings, newest first→ View the original filing at www.sec.gov→